Non-alcoholic fatty liver disease: time for changes
The review contains updated information on the epidemiology, etiology, pathogenesis, diagnosis, treatment and prevention of non-alcoholic fatty liver disease (NAFLD). We searched for terms including NAFLD, non-alcoholic steatohepatitis (NASH), metabolic syndrome and type 2 diabetes mellitus in liter...
| Published in: | Mìžnarodnij Endokrinologìčnij Žurnal |
|---|---|
| Main Authors: | T.I. Yefimenko, M.R. Mykytyuk |
| Format: | Article |
| Language: | English |
| Published: |
Zaslavsky O.Yu.
2021-06-01
|
| Subjects: | |
| Online Access: | http://iej.zaslavsky.com.ua/article/view/237350 |
Similar Items
Overlapping group between non‐alcoholic fatty liver disease and metabolic associated fatty liver disease better for liver research
by: Yu‐Ming Cheng, et al.
Published: (2024-10-01)
by: Yu‐Ming Cheng, et al.
Published: (2024-10-01)
Research Progress in the Correlation of Non-alcoholic Fatty Liver Disease and Metabolic-associated Fatty Liver Disease with Cardiovascular Diseases in China and Abroad
by: NI Xuetong, WANG Ruoxi, ZHANG Jing, YANG Xinghua
Published: (2024-06-01)
by: NI Xuetong, WANG Ruoxi, ZHANG Jing, YANG Xinghua
Published: (2024-06-01)
Metabolic and nutritional aspects of non-alcoholic fatty liver disease
by: O. N. Gerasimenko, et al.
Published: (2022-07-01)
by: O. N. Gerasimenko, et al.
Published: (2022-07-01)
Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia
by: Yohwan Lim, et al.
Published: (2023-06-01)
by: Yohwan Lim, et al.
Published: (2023-06-01)
Non-Alcoholic Fatty Liver Disease and COVID-19–Two Pandemics Hitting at the Same Time
by: Luka Vranić, et al.
Published: (2021-10-01)
by: Luka Vranić, et al.
Published: (2021-10-01)
Draft Clinical Guidelines for the Diagnosis and Treatment of Metabolically Associated Fatty Liver Disease in Children (Non-Alcoholic Fatty Liver Disease)
by: Alexander A. Baranov, et al.
Published: (2025-05-01)
by: Alexander A. Baranov, et al.
Published: (2025-05-01)
Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease
by: Divyavani Gowda, et al.
Published: (2023-11-01)
by: Divyavani Gowda, et al.
Published: (2023-11-01)
Non‐alcoholic fatty liver disease and type 2 diabetes: An update
by: Chi‐H Lee, et al.
Published: (2022-06-01)
by: Chi‐H Lee, et al.
Published: (2022-06-01)
Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
by: Cheng-Wei Yu, et al.
Published: (2023-12-01)
by: Cheng-Wei Yu, et al.
Published: (2023-12-01)
Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease
by: Kalliopi Zachou, et al.
Published: (2023-08-01)
by: Kalliopi Zachou, et al.
Published: (2023-08-01)
Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma
by: Ji-Qiao Zhu, et al.
Published: (2024-04-01)
by: Ji-Qiao Zhu, et al.
Published: (2024-04-01)
Comparison of all-cause mortality associated with non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease in Taiwan MJ cohort
by: Wei-Chun Cheng, et al.
Published: (2024-01-01)
by: Wei-Chun Cheng, et al.
Published: (2024-01-01)
The evolution of artificial intelligence technology in non-alcoholic fatty liver disease
by: Jiawen He, et al.
Published: (2025-09-01)
by: Jiawen He, et al.
Published: (2025-09-01)
Non-alcoholic fatty liver disease: aspects of management of a comorbid patient. A review
by: Tatiana Y. Demidova, et al.
Published: (2023-11-01)
by: Tatiana Y. Demidova, et al.
Published: (2023-11-01)
Changes in indicators of fibrosis in patients with alcoholic liver cirrhosis associated with non-alcoholic fatty liver disease depending on the stage of cirrhosis
by: N. R. Matkovska, et al.
Published: (2020-06-01)
by: N. R. Matkovska, et al.
Published: (2020-06-01)
A Review: Cytochrome P450 in Alcoholic and Non-Alcoholic Fatty Liver Disease
by: Jiang YJ, et al.
Published: (2024-04-01)
by: Jiang YJ, et al.
Published: (2024-04-01)
Outcomes of fatty liver disease with and without metabolic comorbidities and risk factors for mortality
by: Yuri Ogasawara, et al.
Published: (2023-06-01)
by: Yuri Ogasawara, et al.
Published: (2023-06-01)
Arterial stiffness in non-alcoholic fatty liver disease
by: T.V. Chendey, et al.
Published: (2024-06-01)
by: T.V. Chendey, et al.
Published: (2024-06-01)
Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index for Classification of Patients with Steatotic Liver Disease
by: Akash Roy, et al.
Published: (2024-09-01)
by: Akash Roy, et al.
Published: (2024-09-01)
Mechanisms underpinning the effect of exercise on the non-alcoholic fatty liver disease
by: Mohamed Bekheit, et al.
Published: (2025-02-01)
by: Mohamed Bekheit, et al.
Published: (2025-02-01)
Comparison of the Diagnostic Performance of Steatosis Indices for Discrimination of CT-Diagnosed Metabolic Dysfunction-Associated Fatty Liver Disease
by: A. Lum Han, et al.
Published: (2022-07-01)
by: A. Lum Han, et al.
Published: (2022-07-01)
Mean Platelet Volume in Patients with Non-Alcoholic Fatty Liver Disease
by: Miryala Srikar, et al.
Published: (2021-07-01)
by: Miryala Srikar, et al.
Published: (2021-07-01)
Association of Lipid Profile and Liver Parameters with Different Grades of Non-alcoholic Fatty Liver Disease
by: Drutpal Baghel, et al.
Published: (2023-03-01)
by: Drutpal Baghel, et al.
Published: (2023-03-01)
Evaluation of comorbidity in patients with alcoholic cirrhosis of the liver associated with non-alcoholic fatty liver disease
by: N. R. Matkovska, et al.
Published: (2020-04-01)
by: N. R. Matkovska, et al.
Published: (2020-04-01)
The prevalence of metabolic syndrome in patients with non-alcoholic fatty liver disease in Erbil city
by: Maryam Abdulwahid, et al.
Published: (2024-12-01)
by: Maryam Abdulwahid, et al.
Published: (2024-12-01)
Metabolic dysfunction-associated fatty liver disease/metabolic dysfunction-associated steatotic liver disease: general provisions
by: O.E. Abaturov, et al.
Published: (2024-04-01)
by: O.E. Abaturov, et al.
Published: (2024-04-01)
Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease
by: Marium Ahmed, et al.
Published: (2024-04-01)
by: Marium Ahmed, et al.
Published: (2024-04-01)
Fibrotic Burden in the Liver Differs Across Metabolic Dysfunction-Associated Fatty Liver Disease Subtypes
by: Tae Seop Lim, et al.
Published: (2023-07-01)
by: Tae Seop Lim, et al.
Published: (2023-07-01)
The Calculation and Evaluation of an Ultrasound-Estimated Fat Fraction in Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease
by: Pál Novák Kaposi, et al.
Published: (2023-10-01)
by: Pál Novák Kaposi, et al.
Published: (2023-10-01)
The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
by: Teodora Biciusca, et al.
Published: (2023-10-01)
by: Teodora Biciusca, et al.
Published: (2023-10-01)
Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease
by: Kun-Lin Cheng, et al.
Published: (2024-01-01)
by: Kun-Lin Cheng, et al.
Published: (2024-01-01)
Bioengineering scalable and drug-responsive in vitro human multicellular non-alcoholic fatty liver disease microtissues encapsulated in the liver extracellular matrix-derived hydrogel
by: Negar Asadollahi, et al.
Published: (2024-03-01)
by: Negar Asadollahi, et al.
Published: (2024-03-01)
Non-alcoholic fatty liver disease: current aspects of diagnosis in real clinical practice
by: Dmitry I. Trukhan
Published: (2021-04-01)
by: Dmitry I. Trukhan
Published: (2021-04-01)
The Frequency of Non-Alcoholic Fatty Liver Disease in Adults with Diabetes Mellitus
by: Raheel Akhtar Yousafzai, et al.
Published: (2023-08-01)
by: Raheel Akhtar Yousafzai, et al.
Published: (2023-08-01)
Risk factors and predictors of non-alcoholic fatty liver disease in Taiwan
by: Ying-Chin Lin, et al.
Published: (2011-04-01)
by: Ying-Chin Lin, et al.
Published: (2011-04-01)
Association of Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease with COVID-19-Related Intensive Care Unit Outcomes: A Systematic Review and Meta-Analysis
by: Gowthami Sai Kogilathota Jagirdhar, et al.
Published: (2023-07-01)
by: Gowthami Sai Kogilathota Jagirdhar, et al.
Published: (2023-07-01)
The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
by: Hyunwoo Oh, et al.
Published: (2023-02-01)
by: Hyunwoo Oh, et al.
Published: (2023-02-01)
Comparison of long‐term prognosis between non‐obese and obese patients with non‐alcoholic fatty liver disease
by: Michihiro Iwaki, et al.
Published: (2022-10-01)
by: Michihiro Iwaki, et al.
Published: (2022-10-01)
Lysophospholipid metabolism and signalling in non-alcoholic fatty liver disease
by: Charalambos Papadopoulos, et al.
Published: (2022-02-01)
by: Charalambos Papadopoulos, et al.
Published: (2022-02-01)
Atherogenic Index of Plasma in Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2022-08-01)
by: Abdulrahman Ismaiel, et al.
Published: (2022-08-01)
Similar Items
-
Overlapping group between non‐alcoholic fatty liver disease and metabolic associated fatty liver disease better for liver research
by: Yu‐Ming Cheng, et al.
Published: (2024-10-01) -
Research Progress in the Correlation of Non-alcoholic Fatty Liver Disease and Metabolic-associated Fatty Liver Disease with Cardiovascular Diseases in China and Abroad
by: NI Xuetong, WANG Ruoxi, ZHANG Jing, YANG Xinghua
Published: (2024-06-01) -
Metabolic and nutritional aspects of non-alcoholic fatty liver disease
by: O. N. Gerasimenko, et al.
Published: (2022-07-01) -
Non-Alcoholic Fatty Liver Disease, Atherosclerosis, and Cardiovascular Disease in Asia
by: Yohwan Lim, et al.
Published: (2023-06-01) -
Non-Alcoholic Fatty Liver Disease and COVID-19–Two Pandemics Hitting at the Same Time
by: Luka Vranić, et al.
Published: (2021-10-01)
